ARS Pharmaceuticals Inc (SPRY)
14.32
-0.19
(-1.31%)
USD |
NASDAQ |
Sep 27, 16:00
14.32
0.00 (0.00%)
Pre-Market: 20:00
ARS Pharmaceuticals Profit Margin (Quarterly): -2.50K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -2.50K% |
March 31, 2024 | |
December 31, 2023 | |
September 30, 2023 | |
June 30, 2023 | -173.7K% |
Date | Value |
---|---|
March 31, 2023 | -74.80K% |
December 31, 2022 | |
September 30, 2022 | -3.48K% |
June 30, 2022 | -1.38K% |
March 31, 2022 | -1.09K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-173.7K%
Minimum
Jun 2023
-1.09K%
Maximum
Mar 2022
-42.83K%
Average
-2.99K%
Median
Profit Margin (Quarterly) Benchmarks
Aquestive Therapeutics Inc | -13.66% |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | -3.67K% |
IGC Pharma Inc | -874.3% |
NovaBay Pharmaceuticals Inc | -66.04% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -19.40% |
Return on Assets | -18.84% |
Return on Invested Capital | -19.40% |
Operating Margin (Quarterly) | -3.07K% |
Return on Net Operating Assets | -1.16K% |